Elicio’s stock is traded on the NASDAQ global market under the symbol ELTX. Elicio went public through a reverse merger in June 2023. Our CUSIP number is 28657F103.

We are incorporated in Delaware.
Our headquarters are located at 451 D Street, Suite 501, Boston, MA 02210
Our CIK number is 1601485.
Shares may be purchased through a financial services provider of your choice. Elicio does not have a direct stock purchase plan.
Currently Elicio Therapeutics does not offer a dividend or stock reinvestment plan.

By regular mail/overnight courier:
Continental Stock Transfer & Trust Company1 State Street, 30th Floor
New York, NY 10004-1561

Telephone: (212) 509-4000
Facsimile: (212) 616-7613
Email: cstmail@continentalstock.com

You must contact our transfer agent. They can look up your records and make any necessary adjustments. There is a fee involved for replacing lost certificates.

You can get them on our website or you can send a request by email to info@elicio.com.

Investor Relations Contact

Heather DiVecchia
Elicio Therapeutics
Tel: (857) 209-0153

Email Alerts Sign-Up